AbbVie Inc. Dividends, Common Stock, Cash
AbbVie Inc. (ABBV) reported Dividends, Common Stock, Cash of $3.07 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements
us-gaap:DividendsCommonStockCash · last filed 2026-08-03
- AbbVie Inc. dividends, common stock, cash for the quarter ending 2026-06-30 was $3.07B, a 5.49% increase year-over-year.
- AbbVie Inc. dividends, common stock, cash for the quarter ending 2026-03-31 was $3.07B, a 5.53% increase year-over-year.
- AbbVie Inc. dividends, common stock, cash for the quarter ending 2025-12-31 was $3.08B, a 5.53% increase year-over-year.
- AbbVie Inc. dividends, common stock, cash for the quarter ending 2025-09-30 was $2.92B, a 5.80% increase year-over-year.
- AbbVie Inc. dividends, common stock, cash for fiscal 2025 was $11.82B, a 5.73% increase from fiscal 2024.
- AbbVie Inc. dividends, common stock, cash for fiscal 2024 was $11.18B, a 4.99% increase from fiscal 2023.
- AbbVie Inc. dividends, common stock, cash for fiscal 2023 was $10.65B, a 4.60% increase from fiscal 2022.
- AbbVie Inc. dividends, common stock, cash for fiscal 2022 was $10.18B, a 7.49% increase from fiscal 2021.
| Period end | Dividends, Common Stock, Cash 3 month | Dividends, Common Stock, Cash 6 month | Dividends, Common Stock, Cash 9 month | Dividends, Common Stock, Cash 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.07B 10-Q · filed 2026-08-03 | $6.15B 10-Q · filed 2026-08-03 | $9.22B derived: sum of 3 quarters · filed 2026-08-03 | $12.14B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $3.07B 10-Q · filed 2026-05-08 | $6.15B derived: sum of 2 quarters · filed 2026-05-08 | $9.07B derived: sum of 3 quarters · filed 2026-05-08 | $11.98B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $3.08B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.99B derived: sum of 2 quarters · filed 2026-02-20 | $8.91B derived: sum of 3 quarters · filed 2026-08-03 | $11.82B 10-K · filed 2026-02-20 |
| 2025-09-30 | $2.92B 10-Q · filed 2025-11-04 | $5.83B derived: sum of 2 quarters · filed 2026-08-03 | $8.74B 10-Q · filed 2025-11-04 | $11.66B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $2.91B 10-Q · filed 2026-08-03 | $5.83B 10-Q · filed 2026-08-03 | $8.74B derived: sum of 3 quarters · filed 2026-08-03 | $11.50B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $2.91B 10-Q · filed 2026-05-08 | $5.83B derived: sum of 2 quarters · filed 2026-05-08 | $8.58B derived: sum of 3 quarters · filed 2026-05-08 | $11.34B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.67B derived: sum of 2 quarters · filed 2026-02-20 | $8.43B derived: sum of 3 quarters · filed 2026-02-20 | $11.18B 10-K · filed 2026-02-20 |
| 2024-09-30 | $2.76B 10-Q · filed 2025-11-04 | $5.51B derived: sum of 2 quarters · filed 2025-11-04 | $8.26B 10-Q · filed 2025-11-04 | $11.02B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $2.75B 10-Q · filed 2025-08-04 | $5.51B 10-Q · filed 2025-08-04 | $8.26B derived: sum of 3 quarters · filed 2026-02-20 | $10.90B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $2.75B 10-Q · filed 2025-05-09 | $5.51B derived: sum of 2 quarters · filed 2026-02-20 | $8.14B derived: sum of 3 quarters · filed 2026-02-20 | $10.77B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.39B derived: sum of 2 quarters · filed 2026-02-20 | $8.02B derived: sum of 3 quarters · filed 2026-02-20 | $10.65B 10-K · filed 2026-02-20 |
| 2023-09-30 | $2.63B 10-Q · filed 2024-11-04 | $5.26B derived: sum of 2 quarters · filed 2024-11-04 | $7.89B 10-Q · filed 2024-11-04 | $10.53B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $2.63B 10-Q · filed 2024-08-07 | $5.26B 10-Q · filed 2024-08-07 | $7.90B derived: sum of 3 quarters · filed 2025-02-14 | $10.41B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $2.63B 10-Q · filed 2024-05-03 | $5.27B derived: sum of 2 quarters · filed 2025-02-14 | $7.78B derived: sum of 3 quarters · filed 2025-02-14 | $10.29B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $2.64B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $5.15B derived: sum of 2 quarters · filed 2025-02-14 | $7.67B derived: sum of 3 quarters · filed 2025-02-14 | $10.18B 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.51B 10-Q · filed 2023-11-06 | $5.02B derived: sum of 2 quarters · filed 2023-11-06 | $7.54B 10-Q · filed 2023-11-06 | $10.05B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $2.51B 10-Q · filed 2023-08-07 | $5.03B 10-Q · filed 2023-08-07 | $7.54B derived: sum of 3 quarters · filed 2024-02-20 | $9.86B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $2.51B 10-Q · filed 2023-05-05 | $5.03B derived: sum of 2 quarters · filed 2024-02-20 | $7.35B derived: sum of 3 quarters · filed 2024-02-20 | $9.67B derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $2.52B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.84B derived: sum of 2 quarters · filed 2024-02-20 | $7.15B derived: sum of 3 quarters · filed 2024-02-20 | $9.47B 10-K · filed 2024-02-20 |
| 2021-09-30 | $2.32B 10-Q · filed 2022-11-04 | $4.64B derived: sum of 2 quarters · filed 2022-11-04 | $6.95B 10-Q · filed 2022-11-04 | $9.27B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $2.32B 10-Q · filed 2022-08-04 | $4.63B 10-Q · filed 2022-08-04 | $6.95B derived: sum of 3 quarters · filed 2023-02-17 | $9.05B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $2.32B 10-Q · filed 2022-05-06 | $4.63B derived: sum of 2 quarters · filed 2023-02-17 | $6.74B derived: sum of 3 quarters · filed 2023-02-17 | $8.84B derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $2.32B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $4.42B derived: sum of 2 quarters · filed 2023-02-17 | $6.52B derived: sum of 3 quarters · filed 2023-02-17 | $8.28B 10-K · filed 2023-02-17 |
| 2020-09-30 | $2.10B 10-Q · filed 2021-11-02 | $4.21B derived: sum of 2 quarters · filed 2021-11-02 | $5.96B 10-Q · filed 2021-11-02 | $7.72B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $2.10B 10-Q · filed 2021-08-02 | $3.86B 10-Q · filed 2021-08-02 | $5.62B derived: sum of 3 quarters · filed 2022-02-18 | $7.21B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $1.75B 10-Q · filed 2021-05-07 | $3.51B derived: sum of 2 quarters · filed 2022-02-18 | $5.11B derived: sum of 3 quarters · filed 2022-02-18 | $6.70B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $1.76B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $3.35B derived: sum of 2 quarters · filed 2022-02-18 | $4.94B derived: sum of 3 quarters · filed 2022-02-18 | $6.53B 10-K · filed 2022-02-18 |
| 2019-09-30 | $1.59B 10-Q · filed 2020-11-04 | $3.19B derived: sum of 2 quarters · filed 2020-11-04 | $4.78B 10-Q · filed 2020-11-04 | $6.37B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $1.59B 10-Q · filed 2020-08-04 | $3.18B 10-Q · filed 2020-08-04 | $4.78B derived: sum of 3 quarters · filed 2021-02-19 | $6.23B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $1.59B 10-Q · filed 2020-05-08 | $3.19B derived: sum of 2 quarters · filed 2021-02-19 | $4.64B derived: sum of 3 quarters · filed 2021-02-19 | $6.10B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $3.05B derived: sum of 2 quarters · filed 2021-02-19 | $4.51B derived: sum of 3 quarters · filed 2021-02-19 | $6.04B 10-K · filed 2021-02-19 |
| 2018-09-30 | $1.45B 10-Q · filed 2019-11-06 | $2.92B derived: sum of 2 quarters · filed 2019-11-06 | $4.45B 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $1.47B 10-Q · filed 2019-08-05 | $3.00B 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $1.53B 10-Q · filed 2019-05-03 | |||
| 2017-12-31 | $4.22B 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $3.82B 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $3.43B 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $2.81B 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $642.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $1.28B derived: sum of 2 quarters · filed 2016-02-19 | $1.92B derived: sum of 3 quarters · filed 2016-02-19 | $2.56B 10-K · filed 2016-02-19 |
| 2013-09-30 | $641.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.28B derived: sum of 2 quarters · filed 2013-11-12 | $1.92B 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $640.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.28B 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $638.00M 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |